PASITHEA THERAPEUTICS CORP (KTTA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.58-0.07%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · KTTA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | — | — | — | 0.5 | 0.0 | — |
| Total Revenues | — | — | — | — | 0.5 | 0.0 | — |
| Cost of Revenues | — | — | — | — | 0.1 | 0.0 | — |
| Gross Profit | — | — | — | — | — | (0.0) | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | — | — | 7.1 | 7.9 | 9.9 | 4.5 | — |
| R&D Expenses | 10.7 | 8.0 | 7.2 | 8.1 | 2.7 | — | — |
| Operating Income | (24.0) | (20.9) | (14.2) | (16.0) | (12.6) | (4.5) | — |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | — | 0.0 | 0.0 | — |
| Other Non-Operating Income / Expenses | 2.2 | 0.4 | 0.3 | 0.5 | — | 2.3 | — |
| Asset Writedown | — | 4.2 | — | — | — | — | — |
| EBT, Incl. Unusual Items | (21.3) | (20.4) | (13.9) | (15.5) | (11.7) | (2.2) | — |
| Net Income | |||||||
| Net Income | (21.3) | (20.4) | (13.9) | (16.0) | (13.9) | (2.2) | — |
| Per Share | |||||||
| Basic EPS | (0.66) | (2.91) | — | (0.42) | (1.76) | (0.21) | — |
| Diluted EPS | (0.66) | (2.91) | — | (0.42) | (1.76) | (0.21) | — |
| Basic Weighted Avg Shares | 32.1 | 7.0 | 1.1 | 1.2 | 1.3 | 10.4 | — |
| Diluted Weighted Avg Shares | 32.1 | 7.0 | 1.1 | 1.2 | 1.3 | 10.4 | — |
| Supplemental | |||||||
| EBIT | (24.0) | (20.9) | (14.2) | (16.0) | (12.6) | (4.5) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.